Lumea, a global leader in integrated digital pathology solutions and Verily, an Alphabet precision health company, announced a strategic development partnership.

April 27, 2022 — Lumea, a global leader in integrated digital pathology solutions and Verily, an Alphabet precision health company, announced a strategic development partnership. The agreement brings together Verily’s cutting edge artificial intelligence (AI) algorithms with Lumea’s comprehensive end-to-end digital pathology platform with the objective to develop products which can diagnose, prognose, and guide prostate cancer therapy selection with improved objectivity and efficiency.

According to the National Cancer Institute (NCI), in 2021 nearly 250,000 Americans were diagnosed with prostate cancer, and it is the second most common cause of cancer death among men in the country. New approaches in research and prostate cancer diagnosis and detection at an earlier stage are critical to improve mortality.  Currently, the Gleason grading system allows pathologists to analyze tissue growth patterns and aggressiveness, and new research has shown AI systems may help provide more accurate and optimal outcomes.  

Verily has developed AI systems for digital pathology to reduce variability and maximize insights from biopsy tissue samples.  This novel approach enables a new way to understand cancer by eliminating variability, generating more information with less tissue and providing advanced computation to empower both researchers and clinicians.

The Verily-Lumea collaboration goal will be to accomplish the following: 

  • Utilize Lumea’s digital pathology platform and extensive database of pathology cases to enable Verily to validate its Gleason algorithms for prostate cancer developed in partnership with Google Health
  • Integrate Verily’s algorithms into Lumea’s digital pathology platform. Pathologists will then have access to Verily’s AI to assist in identifying and grading prostate cancer within their existing digital workflow

“Verily’s Digital Pathology technologies have the promise to provide more efficient and valuable techniques to democratize access to precision oncology” said Jessica Mega, MD, MPH, Verily Chief Medical & Scientific Officer, Co-Founder.  “Lumea’s integrated digital pathology solution was the ideal technology platform for us to validate our artificial intelligence method to improve cancer detection and grading.” 

“Partnering with Verily will give Lumea’s customers access to world class AI without having to leave their workflow for another system or viewer. Verily’s algorithms will assist pathologists in both identifying and grading prostate cancer. These technology solutions will elevate patient care by giving physicians advanced tools to improve cancer diagnosis,” said John Wirthlin, Lumea CEO. 

For more information: www.lumea.net

Find more on digital pathology here


Related Content

News | SIIM

June 20, 2024 — The Society for Imaging Informatics in Medicine (SIIM) is gearing up for its SIIM24 Annual Meeting and ...

Time June 20, 2024
arrow
News | Artificial Intelligence

June 17, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...

Time June 17, 2024
arrow
News | Radiopharmaceuticals and Tracers

June 7, 2024 — Shine Technologies, LLC, a pioneer in next-generation fusion-based technology, today announced a new ...

Time June 07, 2024
arrow
News | Digital Radiography (DR)

June 6, 2024 — In a landmark study, the latest in technology innovation by Konica Minolta Healthcare was used to develop ...

Time June 06, 2024
arrow
News | Breast Imaging

June 4, 2024 — Using artificial intelligence (AI), breast radiologists in Denmark have improved breast cancer screening ...

Time June 04, 2024
arrow
News | Information Technology

June 4, 2024 — International medical imaging IT and cybersecurity company Sectra has launched a new diagnostic IT module ...

Time June 04, 2024
arrow
Feature | Artificial Intelligence

Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...

Time June 03, 2024
arrow
News | Lung Imaging

May 31, 2024 — To further the fight against global lung cancer, Qure.ai, a leader in healthcare artificial intelligence ...

Time May 31, 2024
arrow
News | Artificial Intelligence

May 30, 2024 — Paige, a global leader in end-to-end digital pathology solutions and artificial intelligence (AI) ...

Time May 30, 2024
arrow
News | RSNA

May 29, 2024 — The Radiological Society of North America (RSNA) has launched the 2024 RSNA Lumbar Spine Degenerative ...

Time May 29, 2024
arrow
Subscribe Now